OriGene Raises $21.3 Million from China Investors

OriGene Technologies of Maryland has raised $21.3 million in a C round that was led by two China-focused venture funds: Qiming Venture Partners and Kleiner Perkins Caufield Byers China. OriGene is a research tool company that offers an extensive portfolio of full-length human cDNAs in a standard expression vector. Although OriGene is headquartered close to Washington DC, it has three facilities in China. More details.... Share this with colleagues: // //